Sung‐Hsin Kuo
Papers
1
Total Citations
6
H-Index
1
About
Dr. Sung-Hsin Kuo is a leading radiation oncologist whose research focuses on the intersection of advanced radiotherapy techniques and complex cardiac arrhythmias. His most prominent contribution lies in the emerging field of noninvasive cardiac radioablation for ventricular tachycardia (VT), where he has pioneered dosimetric comparisons between different treatment platforms. In his highly cited 2023 study, Dr. Kuo conducted the first detailed dosimetric comparison between linear accelerator (LA)-based systems and the robotic CyberKnife (CK) radiosurgery system for cardiac radioablation. This work is critical for optimizing treatment planning, as it evaluates how each system distributes radiation to the arrhythmogenic substrate while minimizing dose to surrounding healthy heart tissue and organs at risk. By providing quantitative evidence on the strengths and limitations of each platform, Dr. Kuo’s research directly informs clinical decision-making, helping radiation oncologists select the most appropriate technology for individual VT patients. His contributions are particularly impactful given the rapid growth of stereotactic arrhythmia radioablation (STAR), and his dosimetric analyses are foundational for ensuring both the safety and efficacy of this noninvasive, life-saving procedure.
Research Focus
Key Achievements
Top Papers
- 1